Biomarin Pharmaceutical Inc

DEUTSCHE BANK AG\ BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

687,658

Value ($000)

40,868

Weight

0.0%

2013 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	40,868	0.0%	687,658	12/31/2025
2025 Q3	11/13/2025	58,817	0.0%	1,085,983	9/30/2025
2025 Q2	8/12/2025	48,815	0.0%	888,029	6/30/2025
2025 Q1	5/9/2025	133,417	0.1%	1,887,353	3/31/2025
2024 Q4	6/30/2025	109,737	0.0%	1,669,518	12/31/2024
2024 Q3	6/26/2025	108,680	0.0%	1,546,167	9/30/2024
2024 Q2	6/12/2025	148,773	0.1%	1,807,032	6/30/2024
2024 Q1	6/2/2025	204,309	0.1%	2,339,236	3/31/2024
2023 Q4	2/14/2024	328,040	0.2%	3,402,197	12/31/2023
2023 Q3	11/24/2023	123,759	0.1%	1,398,719	9/30/2023
2023 Q2	8/14/2023	172,927	0.1%	1,995,006	6/30/2023
2023 Q1	5/15/2023	203,890	0.1%	2,096,775	3/31/2023
2022 Q4	2/13/2023	247,213	0.1%	2,388,766	12/31/2022
2022 Q3	11/14/2022	187,645	0.1%	2,213,574	9/30/2022
2022 Q2	8/11/2022	101,648	0.1%	1,226,578	6/30/2022
2022 Q1	5/13/2022	68,712	0.0%	891,181	3/31/2022
2021 Q4	2/16/2022	83,146	0.0%	941,095	12/31/2021
2021 Q3	11/4/2021	69,012	0.0%	892,879	9/30/2021
2021 Q2	8/11/2021	98,200	0.0%	1,176,891	6/30/2021
2021 Q1	5/13/2021	85,937	0.0%	1,138,091	3/31/2021
2020 Q4	2/16/2021	92,809	0.1%	1,058,375	12/31/2020
2020 Q3	11/12/2020	104,499	0.1%	1,373,548	9/30/2020
2020 Q2	8/13/2020	184,029	0.1%	1,492,056	6/30/2020
2020 Q1	5/14/2020	125,343	0.1%	1,483,313	3/31/2020
2019 Q4	2/14/2020	110,008	0.1%	1,301,177	12/31/2019
2018 Q3	12/21/2021	119,161	—	1,228,836	9/30/2018
2018 Q2	4/21/2020	106,079	—	1,126,090	6/30/2018
2014 Q1	5/15/2014	61,819	0.0%	906,328	3/31/2014
2013 Q4	2/24/2014	87,894	0.1%	1,249,427	12/31/2013